Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20141019019581N5Phase 3Completed
Phase 3, double-blind trial of epinephrine in cataract (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Corneal endothelial cell number and characteristics and Macular thickness. Started Sep 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20141019019581N5.